相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
Akshay S. Desai et al.
EUROPEAN HEART JOURNAL (2015)
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
Chris J. Watson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damage
Hui-Yu Bai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)
Wei Song et al.
GENE (2015)
Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy
Thomas G. von Lueder et al.
CIRCULATION-HEART FAILURE (2015)
The potential role of valsartan+AHU377 (LCZ696) in the treatment of heart failure
Adriaan A. Voors et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Effects of the novel angiotensin II receptor type I antagonist, fimasartan on myocardial ischemia/reperfusion injury
Jin Han et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Use of Hydralazine-Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction
Harsh B. Golwala et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
Jessie Gu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema
R. M. Fryer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome
Akira Sezai et al.
CIRCULATION JOURNAL (2007)
Molecular biology of the natriuretic peptide system - Implications for physiology and hypertension
David G. Gardner et al.
HYPERTENSION (2007)
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Gillian L. Booth et al.
LANCET (2006)
B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts -: Fibrosis, myofibroblast conversion, proliferation, and inflammation
AM Kapoun et al.
CIRCULATION RESEARCH (2004)
Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair
H Tsuneyoshi et al.
CIRCULATION (2004)
Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation
N Takahashi et al.
HYPERTENSION RESEARCH (2003)
The effect of diabetes on outcomes of patients with advanced-heart failure in the BEST trial
M Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction
DL Dries et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
I Kishimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)